Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

44.72
Delayed Data
As of Feb 05
 -4.02 / -8.25%
Today’s Change
44.37
Today|||52-Week Range
133.98
-35.60%
Year-to-Date

Today’s Trading

Previous close48.74
Today’s open48.44
Day’s range44.37 - 48.44
Volume326,940
Average volume (3 months)348,790
Market cap$978.5M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-140.06%
Earnings growth (this year)-80.28%
Earnings growth (next 5 years)+25.46%
Revenue growth (last year)-11.81%
P/E ratio--
Price/Sales42.63
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-1.95-8.09%
SAGESAGE Therapeutics In...-3.64-10.36%
EGRXEagle Pharmaceutical...-2.72-4.40%
ADROAduro Biotech Inc-1.21-7.76%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 10, 2016
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$44.0M
Annual profit (last year)-$68.7M
Net profit margin-156.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts

Partner Offers